For: | Radi R, Huang C, Elsey J, Jung YH, Corces VG, Arbiser JL. Indolium 1 Exerts Activity against Vemurafenib-Resistant Melanoma In Vivo. Antioxidants 2022;11:798. [DOI: 10.3390/antiox11050798] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis] |
---|
Number | Citing Articles |
1 | Dar AA, Bezrookove V, Nosrati M, Ice R, Patino JM, Vaquero EM, Parrett B, Leong SP, Kim KB, Debs RJ, Soroceanu L, Miller JR 3rd, Desprez PY, Cleaver JE, Salomonis N, McAllister S, Kashani-Sabet M. Bromodomain inhibition overcomes treatment resistance in distinct molecular subtypes of melanoma. Proc Natl Acad Sci U S A 2022;119:e2206824119. [PMID: 35969744 DOI: 10.1073/pnas.2206824119] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis] |